Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 3
Submit an article Journal homepage
690
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Evolving therapeutic paradigms for multiple myeloma: back to the future

Benjamin M. CherryMultiple Myeloma Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
,
Neha KordeMultiple Myeloma Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
,
Mary KwokMultiple Myeloma Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
,
Mark RoschewskiMultiple Myeloma Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
&
Ola LandgrenMultiple Myeloma Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USACorrespondence[email protected]
Pages 451-463 | Received 29 May 2012, Accepted 27 Jul 2012, Published online: 14 Sep 2012

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yanxia Jin, Yufeng Shang, Hailing Liu, Lu Ding, Xiqin Tong, Honglei Tu, Guolin Yuan & Fuling Zhou. (2019) A Retrospective Analysis: A Novel Index Predicts Survival and Risk-Stratification for Bone Destruction in 419 Newly Diagnosed Multiple Myelomas. OncoTargets and Therapy 12, pages 10587-10596.
Read now
Yongyong Ma, Zhouxiang Jin, Jin Huang, Shujuan Zhou, Haige Ye, Songfu Jiang & Kang Yu. (2014) Quercetin suppresses the proliferation of multiple myeloma cells by down-regulating IQ motif-containing GTPase activating protein 1 expression and extracellular signal-regulated kinase activation. Leukemia & Lymphoma 55:11, pages 2597-2604.
Read now

Articles from other publishers (10)

Saiedeh Razi Soofiyani, Kamran Hosseini, Haleh Forouhandeh, Tohid Ghasemnejad, Vahideh Tarhriz, Parina Asgharian, Željko Reiner, Javad Sharifi-Rad & William C. Cho. (2021) Quercetin as a Novel Therapeutic Approach for Lymphoma. Oxidative Medicine and Cellular Longevity 2021, pages 1-15.
Crossref
Ben Wang, Chongan Huang, Lijie Chen, Daoliang Xu, Gang Zheng, Yifei Zhou, Xiangyang Wang & Xiaolei Zhang. (2019) The Emerging Roles of the Gaseous Signaling Molecules NO, H 2 S, and CO in the Regulation of Stem Cells . ACS Biomaterials Science & Engineering 6:2, pages 798-812.
Crossref
Iryna V. Baranova, Kateryna P. Postovitenko, Iryna A. Iliuk, Sergii P. Kolisnyk, Alla F. Gumeniuk, Vitalii L. Katiukha, Olena V. Dolynna & Iryna V. Kurylenko. (2020) MULTIPLE MYELOMA: CHALLENGES OF DIFFERENTIAL DIAGNOSIS (CLINICAL CASE). Wiadomości Lekarskie 73:1, pages 203-207.
Crossref
Nicola Giuliani & Fabio Malavasi. (2019) Editorial: Immunotherapy in Multiple Myeloma. Frontiers in Immunology 10.
Crossref
Chenyang Lu, Shan Meng, Yanxia Jin, Wanggang Zhang, Zongfang Li, Fang Wang, Feng Wang-Johanning, Yongchang Wei, Hailing Liu, Honglei Tu, Dan Su, Aili He, Xingmei Cao & Fuling Zhou. (2017) A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy. British Journal of Haematology 178:3, pages 413-426.
Crossref
Ola Landgren & S. Vincent Rajkumar. (2016) New Developments in Diagnosis, Prognosis, and Assessment of Response in Multiple Myeloma. Clinical Cancer Research 22:22, pages 5428-5433.
Crossref
Donghua He, Xing Guo, Enfan Zhang, Fuming Zi, Jing Chen, Qingxiao Chen, Xuanru Lin, Li Yang, Yi Li, Wenjun Wu, Yang Yang, Jingsong He & Zhen Cai. (2016) Quercetin induces cell apoptosis of myeloma and displays a synergistic effect with dexamethasone in vitro and in vivo xenograft models . Oncotarget 7:29, pages 45489-45499.
Crossref
Wuchen Wang, Yugyung Lee & Chi H. Lee. (2015) Effects of nitric oxide on stem cell therapy. Biotechnology Advances 33:8, pages 1685-1696.
Crossref
Ima N. Garcia. (2015) Role of Hematopoietic Stem Cell Transplantation in Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 15:2, pages 86-91.
Crossref
Hong Liu & Philip McCarthy. (2013) New Developments in Post-transplant Maintenance Treatment of Multiple Myeloma. Seminars in Oncology 40:5, pages 602-609.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.